| Geoffrey B Pableo, MD | |
|
1798 N Garey Ave, Pomona, CA 91767-2918 | |
| (909) 865-9623 | |
| Not Available |
| Full Name | Geoffrey B Pableo |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 1798 N Garey Ave, Pomona, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790799039 | NPI | - | NPPES |
| 00A850300 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A85030 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pomona Valley Hospital Medical Center | Pomona, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc., today announced that the first patient has been treated with the company's Valiant® Thoracic Stent Graft with the Captivia Delivery System in Medtronic's RESCUE Clinical Study.
Johns Hopkins researchers report that fetal mice — especially males — show signs of brain damage that lasts into their adulthood when they are exposed in the womb to a maternal immune system kicked into high gear by a serious infection or other malady. The findings suggest that some neurologic diseases in humans could be similarly rooted in prenatal exposure to inflammatory immune responses.
Five years ago, University of North Carolina at Chapel Hill researchers first reported finding that the nutrient choline played a critical role in memory and brain function by positively affecting the brain's physical development.
The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients.
› Verified 9 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc., today announced that the first patient has been treated with the company's Valiant® Thoracic Stent Graft with the Captivia Delivery System in Medtronic's RESCUE Clinical Study.
Johns Hopkins researchers report that fetal mice — especially males — show signs of brain damage that lasts into their adulthood when they are exposed in the womb to a maternal immune system kicked into high gear by a serious infection or other malady. The findings suggest that some neurologic diseases in humans could be similarly rooted in prenatal exposure to inflammatory immune responses.
Five years ago, University of North Carolina at Chapel Hill researchers first reported finding that the nutrient choline played a critical role in memory and brain function by positively affecting the brain's physical development.
The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Geoffrey B Pableo, MD 2100 Powell St, Suite 900, Emeryville, CA 94608-1826 Ph: (510) 350-2777 | Geoffrey B Pableo, MD 1798 N Garey Ave, Pomona, CA 91767-2918 Ph: (909) 865-9623 |
News Archive
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc., today announced that the first patient has been treated with the company's Valiant® Thoracic Stent Graft with the Captivia Delivery System in Medtronic's RESCUE Clinical Study.
Johns Hopkins researchers report that fetal mice — especially males — show signs of brain damage that lasts into their adulthood when they are exposed in the womb to a maternal immune system kicked into high gear by a serious infection or other malady. The findings suggest that some neurologic diseases in humans could be similarly rooted in prenatal exposure to inflammatory immune responses.
Five years ago, University of North Carolina at Chapel Hill researchers first reported finding that the nutrient choline played a critical role in memory and brain function by positively affecting the brain's physical development.
The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients.
› Verified 9 days ago
Ms. Sumi T Felix, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1880 N Orange Grove Ave, Pomona, CA 91767 Phone: 909-620-7200 Fax: 909-620-5800 | |
Amy Leann Douglas, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1798 N Garey Ave, Pomona, CA 91767 Phone: 909-865-9500 | |
Wesley A Curry, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1900 Royalty Dr, Suite 200, Pomona, CA 91767 Phone: 909-865-5168 | |
Kenneth K Nakamoto, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1798 N Garey Ave, Pomona, CA 91767 Phone: 909-865-9600 | |
Donald G. Barceloux, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1798 N Garey Ave, Pomona, CA 91767 Phone: 909-865-9600 | |
Gregory William Burke, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1798 North Garey Avenue, Pomona, CA 91767 Phone: 909-865-9600 Fax: 909-865-9623 | |
Ms. Sapna Mary George-mattappally, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1798 N Garey Ave, Pomona, CA 91767 Phone: 909-865-9500 |